about
Fusobacterium nucleatum infection is prevalent in human colorectal carcinomaStrains, Mechanism, and Perspective: Salmonella-Based Cancer TherapyBacteria in Cancer Therapy: Renaissance of an Old ConceptCombined bacterial and viral treatment: a novel anticancer strategySynthetic biology for pharmaceutical drug discoverySynthetic therapeutic gene circuits in mammalian cellsAccessing the inaccessible: molecular tools for bifidobacteriaModeling of chemotactic steering of bacteria-based microrobot using a population-scale approach.Targeted Cancer Therapy Using Engineered Salmonella typhimuriumImpediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapyA Phytase-Based Reporter System for Identification of Functional Secretion Signals in BifidobacteriaSynthetic genomics and synthetic biology applications between hopes and concernsSynthetic biology expands chemical control of microorganismsViolacein as a genetically-controlled, enzymatically amplified and photobleaching-resistant chromophore for optoacoustic bacterial imaging.New paradigm for tumor theranostic methodology using bacteria-based microrobot.Programming controlled adhesion of E. coli to target surfaces, cells, and tumors with synthetic adhesins.Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI.Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivoCytolethal Distending Toxin Enhances Radiosensitivity in Prostate Cancer Cells by Regulating Autophagy.Direct injection of functional single-domain antibodies from E. coli into human cells.Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growthBioadhesive Bacterial Microswimmers for Targeted Drug Delivery in the Urinary and Gastrointestinal Tracts.Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility.Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors.Towards a synthetic chloroplast.Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimuriumA bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapyTumor-targeting bacterial therapy: A potential treatment for oral cancer (Review)Evaluation of Gram-negative bacterial infection by a stable and conjugative bioluminescence plasmid in a mouse modelA novel balanced-lethal host-vector system based on glmS.Engineering and visualization of bacteria for targeting infarcted myocardiumTrg-deficient Salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating.Synthetic biology for therapeutic applications.Targeting tumors with salmonella Typhimurium- potential for therapy.Toward a high-throughput screening platform for directed evolution of enzymes that activate genotoxic prodrugs.Basic regulatory principles of Escherichia coli's electron transport chain for varying oxygen conditions.Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses.Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis.Potent and tumor specific: arming bacteria with therapeutic proteins.Violacein induces p44/42 mitogen-activated protein kinase-mediated solid tumor cell death and inhibits tumor cell migration
P2860
Q24603069-0F368730-C15A-4692-B681-952C6695FF12Q26748794-987E3621-E252-433B-BADE-5003AB98D022Q26751222-2CD55C37-2A9B-4D53-A05E-35B48C8DB4B4Q26773180-327CC086-8A77-4C01-8B1E-2D9FC236A504Q26775582-F972917F-0DE0-4976-B903-5AC60AD24DB8Q26826954-2787FE35-1923-42DB-BB02-FF1F699E2773Q27015839-FE41F2BC-E1B0-477A-8F75-D56255BDD4DBQ27330016-EB13DFC7-048F-46CC-A1D2-AA3EDF5E70E2Q28069354-E419D0AC-230C-498A-8F16-FD46BDACB00CQ28543432-65A04113-58C0-46E7-90CC-2C323F4F49DFQ28548451-DC25A14A-DAD8-42FA-B128-F2E787CD80B0Q28706666-0D3DA3F1-50DD-4C49-A702-0E5231483522Q28828848-4AFBCA0F-2438-4877-99B3-2017774BCD91Q30407035-1519E4E1-B576-4D3E-8BAD-35EECBF9072FQ30558192-3140343B-D4B6-4F0C-A6C8-F60489304C44Q30643835-EB3686B2-0ACD-4EFA-A607-6DF1BD292A44Q30677182-DC62147C-9206-4A0E-A0BE-44C32F80C7EDQ33688369-C2BA87BE-44D7-4C07-B632-A88AAD9D40EDQ33774874-11B127A9-2AEF-416E-9304-3AAFA9EB5F21Q33775617-BF15DBDD-C0C3-4201-905C-F945383A83A4Q33798724-C47219D3-4701-4485-9366-15629F704FF6Q33806268-6D3F5DD2-BD6F-45A4-B138-DA47C48B64E9Q33829542-FD17634E-30F4-47F9-8CA0-E900D462B869Q33870710-116C8813-D9F2-4B92-A2DC-96C7CDB46AD0Q33886250-F318AE2B-B728-489D-9E72-DFD638D9EAC3Q33914020-437A11D8-63E9-47B7-80AE-AFBB2941DBD2Q34315760-44957444-DBF3-4F86-A84F-92668D688051Q34427510-EEA71CCC-01E8-4452-978A-DA4DA38D7D92Q34544482-793CE5DE-F7A3-4E5D-B331-5784B34ADDCCQ34654013-E9757BBE-D90C-49B0-B9C9-0FD75DF3788EQ34994526-A393F793-74AE-4180-8D71-EB9CB37D0ED5Q35020097-08864C7D-6916-4A21-AFE2-EDD4C1D0C152Q35057524-09E01664-5641-4D79-93CB-411750951CEBQ35169604-96CBD7E0-C9EF-42CF-A70F-932828FC26F9Q35201410-F9B7FAC1-298B-43E0-9670-0CB935C2D7CDQ35288407-4181F6A5-207D-4D68-9BC4-E1BE26C62B41Q35446009-5598F61A-0249-4EF8-ABA3-3CBAB5260689Q35550049-04CC91BF-94E9-4077-B355-EAB318CE90B8Q35579375-B8F66851-E5D7-47CD-8955-23504A059500Q35628391-1D9F83F6-D0EF-4EFA-8727-9B5AA3975BD1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on 14 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Engineering the perfect (bacterial) cancer therapy
@en
Engineering the perfect
@nl
type
label
Engineering the perfect (bacterial) cancer therapy
@en
Engineering the perfect
@nl
prefLabel
Engineering the perfect (bacterial) cancer therapy
@en
Engineering the perfect
@nl
P2860
P356
P1476
Engineering the perfect (bacterial) cancer therapy
@en
P2093
Neil S Forbes
P2860
P2888
P304
P356
10.1038/NRC2934
P407
P577
2010-10-14T00:00:00Z